CN101433606B - External-use agent for treating vitiligo - Google Patents

External-use agent for treating vitiligo Download PDF

Info

Publication number
CN101433606B
CN101433606B CN2008101476151A CN200810147615A CN101433606B CN 101433606 B CN101433606 B CN 101433606B CN 2008101476151 A CN2008101476151 A CN 2008101476151A CN 200810147615 A CN200810147615 A CN 200810147615A CN 101433606 B CN101433606 B CN 101433606B
Authority
CN
China
Prior art keywords
ointment
commodity
radix
prescription proportioning
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101476151A
Other languages
Chinese (zh)
Other versions
CN101433606A (en
Inventor
王洪斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101476151A priority Critical patent/CN101433606B/en
Publication of CN101433606A publication Critical patent/CN101433606A/en
Application granted granted Critical
Publication of CN101433606B publication Critical patent/CN101433606B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses an externally used medicament for treating leucoderma, which comprises effective components such as angelica dahurica, white paeony root, rhizome drynariae, lopseed, clematis root, peach kernel, sulfur, blue vitriol, goslarite, and the like. The preparation method comprises the following steps: crushing the effective components of Chinese herbal medicine and then extracting and separating out effective constituents; grinding minerals by glycerin and then pressurizing and filtering the minerals by a screen of 400 meshes; and respectively taking proper filtrate and mixing the filtrate by 50 percent ethanol into turbid suspension, or taking the filtrate according to certain proportion and then using cream to prepare the filtrate into ointment. The medicament has remarkable and unique curative effect for vitiligo and leucoderma diseases caused by depigmentation of skin, and has the advantages of safe use, short treatment course and high curative ratio.

Description

Treat leukodermic topical agent
Technical field
The present invention relates to treat dermopathic key areas.Be specifically related to the leukodermic medicine for external use of a kind of treatment
Background technology
Agent.
Summary of the invention
Vitiligo is a kind of pigmented dermatosis of common pilosity, and this disease is with local or general property depigmentation, and the formation white macula is a characteristic.Be due to the local skin pigment lacks, relevant with the melanin hyposecretion.Generation is all arranged all over the world, and India's sickness rate is the highest, and China has 1,200 ten thousand people morbidity approximately, and primary disease can involve all races, men and women's no marked difference of falling ill.In recent years sickness rate rises year by year, causes people's common concern.White macula, therapy for vitiligo always are the difficult point in the dermatosis field, particularly mucosa and leukoplakia vulvae, more show refractory.
The purpose of this invention is to provide a kind of white macula, vitiligo disease of treating due to the depigmentation of skin, safe in utilization, short treating period, the topical agent that cure rate is high.Particularly in the treatment of facial area, lip mucosa and leukoplakia vulvae, remarkable result is arranged more.
In order to achieve the above object and curative effect, the present invention is processed by following raw materials in weight portion:
The Radix Angelicae Dahuricae 15~25 Radix Paeoniae Albas 10~20 Rhizoma Drynariae 10~20 Herba speranskiae tuberculataes 5~15 Radix Clematidis 5~15
Semen Persicae 5~15 sulfur 5~15 Chalcanthitums 5~25 white vitriols 5~15
50% ethanol: 1000~2000
Glycerol: 500~1000
Frost base: sodium laurylsulfate 50~100.
Optimum weight part proportioning of medicine of the present invention is:
The Radix Angelicae Dahuricae 10 Radix Paeoniae Albas 15 Rhizoma Drynariae 15 Herba speranskiae tuberculataes 10 Radix Clematidis 10
Semen Persicae 10 sulfur 10 Chalcanthitums 15 white vitriols 10
50% ethanol: 1500
Glycerol: 800
Frost base: sodium laurylsulfate etc. 80
Making step of the present invention is following:
(1) Chinese herbal medicine is got and is carried: get the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Rhizoma Drynariae, Herba speranskiae tuberculatae, Radix Clematidis and Semen Persicae by said prescription proportioning and pulverize; Chinese drugs powder after pulverizing is added 50% alcohol solvent by the prescription proportioning, after fully stirring, leave standstill more than 72 hours (stir 2-3 every day).Use four layers of filtered through gauze then.Getting its filtrating A contains in the container bottle subsequent use.
(2) mineral grinds: said prescription proportioning is got sulfur, Chalcanthitum and white vitriol and is pulverized, and the mineral drug powder after pulverizing is pressed the prescription proportioning add the glycerol grinding, then with 400 sieve pressure filtrations.Getting its liquor B contains in the container bottle subsequent use.
(3) finished product:,, liquor B and an amount of 50% ethanol mixing are processed suspension commodity B1 so will filtrate A and an amount of 50% ethanol mixing are processed suspension commodity A1 because of these medicine characteristics are that fresh result of use is best.A1, B1 place the plastics colored bottle respectively.The A that will filtrate mixes to mix thoroughly with an amount of frost base and processes ointment commodity A2, with liquor B with an amount of white basic mix to mix thoroughly process ointment commodity B2.A2, B2 place wide-mouth coloured plastics material box respectively.Place 3-10 ℃ of refrigerator to preserve lucifuge.During use, by different proportion get commodity A1 and B1 mix thoroughly suspension, be coated with the part outward.Perhaps by different proportion get commodity A2 and B2 mix mix thoroughly ointment, be coated with the part outward.
The mechanism of action of the present invention: 1, through oxidation reaction, for local cells provides pigment.2, various trace elements is provided, supplies with cytotrophy.
The present invention becomes for vitiligo, white macula due to the local skin depigmentation, limit office sexually transmitted disease (STD), and medical history had significant especially curative effect in 5 years with interior person.Simultaneously treatment tinea versicolor etc. also there is certain effect.And select for use suspension or ointment to put the part outward on the skin to diseased region.As: the body surface white macula, select suspension for use.Time spent is mixed A1, two kinds of medicines of B1, shakes up, and with the open-minded chopsticks dipping affected part of bamboo let, must not repeatedly overflow in normal skin.Put on the skin 2-3 time every day outward, and it is only normal to become a full member to skin pigment.About medication 10 days, local white macula more whitening is a little, continues to put on the skin then blackening gradually.Facial area, lip mucosa are selected white fundamental mode ointment (white macula ointment) for use.Time spent is mixed A2, B2 two boxes, mixes thoroughly with bamboo let, is applied to affected part, and put on the skin 2-3 time every day outward, and it is only normal to become a full member to pigment.Must not repeatedly overflow in normal skin when being coated with, thickness of covering is opened thick for printing paper 3-5.Medicine generation grey black reaction under photosynthesis behind the coating.
Short treating period of the present invention, cure rate height, local no side reaction, safe in utilization, be fit to a plurality of age group and use, particularly child, teenager.Treatment facial area, lip mucosa, leukoplakia vulvae have significant curative effect, and the patient is prone to grasp use.Its manufacturing process is simple, and dosage form is stable, and cost is more honest and cleaner, but mass production.
Model case
1, Zhao, woman, 4 years old.Left front volume 2cm * 5cm white macula is to scalp, a handful of poliosis on the white macula, and medical history 2 years is diagnosed as vitiligo to various big hospitals such as Chengdu; Fail to respond to any medical treatment, come to go to a doctor, adopt the externally applied liquid treatment on JIUYUE 24th, 20058; Pigmentation was arranged in 3 months, and to recovery from illness in 12 months, poliosis transferred hair color to.
2, for certain, man, 28 years old.Bottom right jaw leukoderma, medical history 4 years is a vitiligo to other hospital diagnosis, comes to go to a doctor on May 25th, 2006.With the externally applied liquid treatment, cured in 12 months.
3, Lee, woman, 20 years old.Place, right forelock border white macula, right hand palmar and refer to a plurality of white maculas came to go to a doctor on July 5th, 2007.Hospital of a few family goes to control repeatedly to the Leshan in readme, and is invalid.Adopt medicament ointment of the present invention to put forehead outward on the skin, every day 3 times.Hand getting is with treatments such as " refining melanoma liquids ".Forehead had pigmentation in three month, and skin pigment was often become a full member in 8 months, and hand was cured in 11 months.
4, Zhang, woman, 15 years old.Two skin of upper extremity white maculas are vitiligo (medical history 5 years) to other hospital diagnosis, fail to respond to any medical treatment.Come to go to a doctor on August 1st, 2007, suspension is put on the skin outward, cures in 8 months.
5, Lu, the woman, 12 years old, facial area white macula many places were vitiligo to how tame hospital diagnosis such as Leshan, Chengdu, medical history 5 years is failed to respond to any medical treatment.Come to go to a doctor on October 13rd, 2007, with the outer liniment for treatment of ointment, skin recovers normal after 56 days.
6, Wang, woman, 37 years old.Right side lip membranous part white macula is a vitiligo to other hospital diagnosis, medical history 1 year.Come to go to a doctor on JIUYUE 6th, 2008.Put on the skin outward with ointment, lip mucosa pigment recovered normal in 52 days.
7, the hair certain, woman, 27 years old.The a plurality of white maculas of right side lower jaw to cervical region are vitiligo to other hospital diagnosis, and medical history 1 year came to go to a doctor on JIUYUE 10th, 2008, put on the skin outward with ointment, cured in 45 days.Specific embodiment
The present invention forms by following proportioning:
The Radix Angelicae Dahuricae 10 Radix Paeoniae Albas 15 Rhizoma Drynariae 15 Herba speranskiae tuberculataes 10 Radix Clematidis 10
Semen Persicae 10 sulfur 10 Chalcanthitums 15 white vitriols 10
50% ethanol: 1500
Glycerol: 800
Frost base: sodium laurylsulfate etc. 80
The present invention makes by following making step:
(1) Chinese herbal medicine is got and is carried: get the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Rhizoma Drynariae, Herba speranskiae tuberculatae, Radix Clematidis and Semen Persicae by said prescription proportioning and pulverize; Chinese drugs powder after pulverizing is added 50% alcohol solvent by the prescription proportioning, after fully stirring, leave standstill more than 72 hours (stir 2-3 every day).Use four layers of filtered through gauze then.Getting its filtrating A contains in the container bottle subsequent use.
(2) mineral grinds: said prescription proportioning is got sulfur, Chalcanthitum and white vitriol and is pulverized, and the mineral drug powder after pulverizing is pressed the prescription proportioning add the glycerol grinding, then with 400 sieve pressure filtrations.Getting its liquor B contains in the container bottle subsequent use.
(3) finished product:,, liquor B and an amount of 50% ethanol mixing are processed suspension commodity B1 so will filtrate A and an amount of 50% ethanol mixing are processed suspension commodity A1 because of these medicine characteristics are that fresh result of use is best.A1, B1 place the plastics colored bottle respectively.The A that will filtrate mixes to mix thoroughly with an amount of frost base and processes ointment commodity A2, with liquor B with an amount of white basic mix to mix thoroughly process ointment commodity B2.A2, B2 place wide-mouth coloured plastics material box respectively.Place 3-10 ℃ of refrigerator to preserve lucifuge.During use, by different proportion get commodity A1 and B1 mix thoroughly suspension, be coated with the part outward.Perhaps by different proportion get commodity A2 and B2 mix mix thoroughly ointment, be coated with the part outward.

Claims (2)

1. treat leukodermic topical agent for one kind, it is characterized in that it is the medicament of being processed by the following weight parts proportion raw material:
The Radix Angelicae Dahuricae 15~25 Radix Paeoniae Albas 10~20 Rhizoma Drynariae 10~20 Herba speranskiae tuberculataes 5~15 Radix Clematidis 5~15
Semen Persicae 5~15 sulfur 5~15 Chalcanthitums 5~25 white vitriols 5~15
50% ethanol: 1000~2000
Glycerol: 500~1000
Frost base: sodium laurylsulfate 50~100;
The making step of the leukodermic topical agent of said treatment is following:
(1) Chinese herbal medicine: get the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Rhizoma Drynariae, Herba speranskiae tuberculatae, Radix Clematidis and Semen Persicae by said prescription proportioning and pulverize; Chinese drugs powder after pulverizing is added 50% alcohol solvent by the prescription proportioning, after fully stirring, leave standstill more than 72 hours, stir 2-3 every day, uses four layers of filtered through gauze then, gets its filtrating A and contain in the container bottle subsequent use;
(2) mineral medicine: get sulfur, Chalcanthitum and white vitriol by said prescription proportioning and pulverize, the mineral drug powder after pulverizing is pressed the prescription proportioning add the glycerol grinding, with 400 sieve pressure filtrations, get its liquor B and contain in container bottle subsequent use then;
(3) allotment and finished product: because of these medicine characteristics are that fresh result of use is best; The A that will filtrate mixes to mix thoroughly with an amount of frost base and processes ointment commodity A2; Liquor B and an amount of frost base mixed to mix thoroughly process ointment commodity B2, A2, B2 place wide-mouth coloured plastics material box respectively, during use; By different proportion get commodity A2 and B2 mix mix thoroughly ointment, be coated with the part outward.
2. treat leukodermic topical agent for one kind, wherein the weight portion proportioning of each raw material is:
The Radix Angelicae Dahuricae 10 Radix Paeoniae Albas 15 Rhizoma Drynariae 15 Herba speranskiae tuberculataes 10 Radix Clematidis 10
Semen Persicae 10 sulfur 10 Chalcanthitums 15 white vitriols 10
50% ethanol: 1500
Glycerol: 800
Frost base: sodium laurylsulfate 80;
The making step of the leukodermic topical agent of said treatment is following:
(1) Chinese herbal medicine: get the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Rhizoma Drynariae, Herba speranskiae tuberculatae, Radix Clematidis and Semen Persicae by said prescription proportioning and pulverize; Chinese drugs powder after pulverizing is added 50% alcohol solvent by the prescription proportioning, after fully stirring, leave standstill more than 72 hours, stir 2-3 every day, uses four layers of filtered through gauze then, gets its filtrating A and contain in the container bottle subsequent use;
(2) mineral medicine: get sulfur, Chalcanthitum and white vitriol by said prescription proportioning and pulverize, the mineral drug powder after pulverizing is pressed the prescription proportioning add the glycerol grinding, with 400 sieve pressure filtrations, get its liquor B and contain in container bottle subsequent use then;
(3) allotment and finished product: because of these medicine characteristics are that fresh result of use is best; The A that will filtrate mixes to mix thoroughly with an amount of frost base and processes ointment commodity A2; Liquor B and an amount of frost base mixed to mix thoroughly process ointment commodity B2, A2, B2 place wide-mouth coloured plastics material box respectively, during use; By different proportion get commodity A2 and B2 mix mix thoroughly ointment, be coated with the part outward.
CN2008101476151A 2008-11-20 2008-11-20 External-use agent for treating vitiligo Expired - Fee Related CN101433606B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101476151A CN101433606B (en) 2008-11-20 2008-11-20 External-use agent for treating vitiligo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101476151A CN101433606B (en) 2008-11-20 2008-11-20 External-use agent for treating vitiligo

Publications (2)

Publication Number Publication Date
CN101433606A CN101433606A (en) 2009-05-20
CN101433606B true CN101433606B (en) 2012-06-27

Family

ID=40708346

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101476151A Expired - Fee Related CN101433606B (en) 2008-11-20 2008-11-20 External-use agent for treating vitiligo

Country Status (1)

Country Link
CN (1) CN101433606B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104257781A (en) * 2014-09-27 2015-01-07 唐国萍 External preparation for treating vitiligo

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1038025A (en) * 1988-05-24 1989-12-20 石家庄市广普应用技术研究所 A kind of manufacture method for the treatment of the leucoderma disease medicine
CN1868514A (en) * 2005-05-23 2006-11-29 林长喜 Traditional Chinese medicine capsule for treating leucoderma, and its prepn. method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1038025A (en) * 1988-05-24 1989-12-20 石家庄市广普应用技术研究所 A kind of manufacture method for the treatment of the leucoderma disease medicine
CN1868514A (en) * 2005-05-23 2006-11-29 林长喜 Traditional Chinese medicine capsule for treating leucoderma, and its prepn. method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
江海燕,江涛.近十年白癜风中医药治疗研究述评.《四川中医》.2001,第19卷(第10期),第15-18页. *

Also Published As

Publication number Publication date
CN101433606A (en) 2009-05-20

Similar Documents

Publication Publication Date Title
CN102391919A (en) Traditional Chinese medicine perfumed soap for removing acne and preventing skin allergy
CN105434207A (en) Cosmetic composition for skin soothing and preparation method thereof
CN101274009A (en) Compound formulation of capsules for curing lumbocrural pain and preparing technique
CN101219096A (en) Pharmaceutical composition for removing speckle, production method and using method thereof
CN101433606B (en) External-use agent for treating vitiligo
CN100571760C (en) The prescription of mouth ulcer bilayer film and preparation technology
CN101120974A (en) External-applied traditional Chinese medicine for treating scabies
CN101239033B (en) Skin-protection speckle-removing cream and preparation thereof
CN106937934A (en) A kind of herbal composite and its preparation method for whitening spot-removing
CN106421581A (en) Biological traditional Chinese medicine for oral administration for treating diabetes and preparation method thereof
CN102772660A (en) Novel traditional Chinese medicinal composition for simultaneously reducing blood fat and blood sugar and method for preparing novel traditional Chinese medicinal composition
CN102485259A (en) Preparation method and application of ginseng fruit medicinal dispersing tablets and buccal tablets
CN108403869B (en) Traditional Chinese medicine composition for removing chloasma and preparation method thereof
CN101732223A (en) Pure traditional Chinese medicine active white skin care solution and preparation method thereof
CN104922371A (en) Use of combination in preparation of medicine for treating transient and chronic tic disorder
CN101439106A (en) Medicament for treating apoplexy
CN101433619B (en) Tinctura for eliminating tinea and relieving itching
CN105326899A (en) Traditional Chinese medicine for treating leukoderma and preparation method for traditional Chinese medicine
CN106938024A (en) Xiaoyin nanometer emulsifiable paste
CN101428103A (en) Formulation for treating senile dementia and Parkinsonismus
CN104706714A (en) Traditional Chinese medicine anti-allergic and bactericidal cream for whitening and removing freckles
CN1449802A (en) Traditional Chinese medicine for treating arthralgia and preparation process thereof
CN101274018A (en) Compound formulation of capsules for curing alopecia and preparing process
CN1449803A (en) Oral medication germinal preparation and making process thereof
CN104840679A (en) Freckle removing and skin whitening drug combination, freckle removing and skin whitening preparation and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120627

Termination date: 20161120

CF01 Termination of patent right due to non-payment of annual fee